N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate

C36H88N16O8 — CID 161173818

IUPACN-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate
SMILESCN1CCN([13CH2][13CH2]NCCON)CC1.CN1CC[15N](C[13CH2]NCCON)[13CH2][13CH2]1.CN1CC[15N]([13CH2]C(=O)NCCON)[13CH2][13CH2]1.CN1CC[15N]([13CH2]C(=[18O])NCCON)CC1.O.[18OH2]
InChIInChI=1S/2C9H20N4O2.2C9H22N4O.2H2O/c2*1-12-3-5-13(6-4-12)8-9(14)11-2-7-15-10;2*1-12-5-7-13(8-6-12)4-2-11-3-9-14-10;;/h2*2-8,10H2,1H3,(H,11,14);2*11H,2-10H2,1H3;2*1H2/i3+1,5+1,8+1,13+1;8+1,13+1,14+2;2+1,5+1,7+1,13+1;2+1,4+1;1+2;
InChIKeyTZBQAABTAMAUFU-HPYQYJSXSA-N
MW889.11 g/mol
LogP-7.74
Rot. Bonds22

About N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate

N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate (PubChem CID 161173818) has the molecular formula C36H88N16O8 and a molecular weight of 889.11 g/mol. Its IUPAC name is N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate.

Molecular Properties

Compound NameN-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate
PubChem CID161173818
Molecular FormulaC36H88N16O8
Molecular Weight889.11 g/mol
Exact Mass888.73
IUPAC NameN-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate
SMILESCN1CCN([13CH2][13CH2]NCCON)CC1.CN1CC[15N](C[13CH2]NCCON)[13CH2][13CH2]1.CN1CC[15N]([13CH2]C(=O)NCCON)[13CH2][13CH2]1.CN1CC[15N]([13CH2]C(=[18O])NCCON)CC1.O.[18OH2]
InChIInChI=1S/2C9H20N4O2.2C9H22N4O.2H2O/c2*1-12-3-5-13(6-4-12)8-9(14)11-2-7-15-10;2*1-12-5-7-13(8-6-12)4-2-11-3-9-14-10;;/h2*2-8,10H2,1H3,(H,11,14);2*11H,2-10H2,1H3;2*1H2/i3+1,5+1,8+1,13+1;8+1,13+1,14+2;2+1,5+1,7+1,13+1;2+1,4+1;1+2;
InChIKeyTZBQAABTAMAUFU-HPYQYJSXSA-N
XLogP-7.74
TPSA312.18 Ų
H-Bond Donors8
H-Bond Acceptors20
Rotatable Bonds22
Heavy Atoms60
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500889.11
LogP ≤ 5-7.74
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate?
The IUPAC name of N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate (CID 161173818) is N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate.
What is the SMILES notation for N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate?
The canonical SMILES for N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate is CN1CCN([13CH2][13CH2]NCCON)CC1.CN1CC[15N](C[13CH2]NCCON)[13CH2][13CH2]1.CN1CC[15N]([13CH2]C(=O)NCCON)[13CH2][13CH2]1.CN1CC[15N]([13CH2]C(=[18O])NCCON)CC1.O.[18OH2].
What is the InChIKey of N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate?
The InChIKey is TZBQAABTAMAUFU-HPYQYJSXSA-N. The full InChI is InChI=1S/2C9H20N4O2.2C9H22N4O.2H2O/c2*1-12-3-5-13(6-4-12)8-9(14)11-2-7-15-10;2*1-12-5-7-13(8-6-12)4-2-11-3-9-14-10;;/h2*2-8,10H2,1H3,(H,11,14);2*11H,2-10H2,1H3;2*1H2/i3+1,5+1,8+1,13+1;8+1,13+1,14+2;2+1,5+1,7+1,13+1;2+1,4+1;1+2;.
What are the key properties of N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate?
N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate has a molecular weight of 889.11 g/mol, XLogP of -7.74, 22 rotatable bonds, 8 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-aminooxyethyl)-2-(4-methyl-(115N)1,4-diazinan-1-yl)acetamide;N-(2-aminooxyethyl)-2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)acetamide;O-[2-[2-(4-methyl-(5,6-13C2,115N)1,4-diazinan-1-yl)(113C)ethylamino]ethyl]hydroxylamine;O-[2-[2-(4-methylpiperazin-1-yl)(1,2-13C2)ethylamino]ethyl]hydroxylamine;oxidane;hydrate is sourced from PubChem (CID 161173818), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).